Last reviewed · How we verify

Sodium Chloride [3%] — Competitive Intelligence Brief

Sodium Chloride [3%] (Sodium Chloride [3%]) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte solution / Osmotic agent. Area: Critical Care / Acute Medicine.

marketed Electrolyte solution / Osmotic agent Critical Care / Acute Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Sodium Chloride [3%] (Sodium Chloride [3%]) — Fundacion Clinica Valle del Lili. Sodium chloride 3% is a hypertonic saline solution that draws fluid from intracellular and interstitial spaces into the vascular compartment through osmotic gradient.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sodium Chloride [3%] TARGET Sodium Chloride [3%] Fundacion Clinica Valle del Lili marketed Electrolyte solution / Osmotic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte solution / Osmotic agent class)

  1. Fundacion Clinica Valle del Lili · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium Chloride [3%] — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-chloride-3. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: